Overview
Putnam BioRevolution ETF (SYNB) is managed by Franklin Templeton. The fund was launched on 2022-09-29 and trades on the NYSE Arca.
Fund Details
- Category: Specialty - Unaligned
- General Category: Sector Equity
- Expense Ratio: 0.00%
- Assets Under Management: $6M
- Actively Managed: Yes
- SEC CIK Code: 1730726
- Benchmark: N/A
Investment Strategy
This Sector Equity fund is actively managed and tracks the N/A.